SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-006536
Filing Date
2023-01-25
Accepted
2023-01-25 16:10:50
Documents
16
Period of Report
2023-01-21
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm234276d1_8k.htm   iXBRL 8-K 31774
2 EXHIBIT 16.1 tm234276d1_ex16-1.htm EX-16.1 4654
3 GRAPHIC tm234276d1_ex16-1img001.jpg GRAPHIC 4991
4 GRAPHIC tm234276d1_ex16-1img002.jpg GRAPHIC 2983
  Complete submission text file 0001104659-23-006536.txt   266691

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA atxi-20230121.xsd EX-101.SCH 3271
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxi-20230121_def.xml EX-101.DEF 26690
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20230121_lab.xml EX-101.LAB 36224
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20230121_pre.xml EX-101.PRE 25348
10 EXTRACTED XBRL INSTANCE DOCUMENT tm234276d1_8k_htm.xml XML 4709
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38114 | Film No.: 23552590
SIC: 2834 Pharmaceutical Preparations